Profile for BioXcel Therapeutics Inc. (BTAI)

$ 37.52 R     -7.19 (-16.08%) Volume: 2.67m 4:00 PM EDT Aug 14, 2020
After Hours:  $ 37.66   0.14 (+0.37%) Volume: 1.58k 7:59 PM EDT Aug 14, 2020
Business Description:
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company which is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology.
Address: 555 Long Wharf Drive, 12th Floor, New Haven, CT, USA, 06511
Telephone: +1 475 238-6837 Website:
Facsimile: +1 475 238-6837 Email: [email protected]
CEO: Vimal Mehta
Employees: 27 Market Cap: 908.41m
Issue Type: CS
Auditor: BDO USA, LLP
Last Audit: Unqualified Opinion
Indices: N/A
Industry Classifications
Sector: Healthcare CIK: 1720893
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: Pharmaceutical Preparation Manufacturing (325412)
SIC: Pharmaceutical Preparations (2834)